Effrosyni Apostolidou, M.D., Ph.D.
Department of Pulmonary Medicine, Division of Internal Medicine
About Dr. Effrosyni Apostolidou
Throughout my career I have had the opportunity and privilege to care for patients with malignant and non-malignant hematologic disorders alike. I have had several years of experience not only in managing patients with malignant and benign disorders of the blood, but also in participating as Co-PI in clinical trials, primarily Phase I trials of novel antileukemic agents, at MD Anderson. I have also led cohort studies related to patient outcomes in diverse patient populations. Over the last 2-3 years I have focused in Classical Hematology, seeing patients with cancer associated thrombotic and hemorrhagic disorders primarily, as well as hematologic complications of cancer treatments. In addition, I carry several leadership roles in administration, education and quality improvement
Present Title & Affiliation
Primary Appointment
Chief ad-interim, Section of Hematology, Pulmonary Medicine, Internal Medicine, The University of Texas MD Anderson Cancer Center
Associate Program Director, MDACC Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, Section of Hematology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, The University of Texas MD Anderson Cancer Center
Education & Training
Degree-Granting Education
| 2004 | National and Kapodistrian University of Athens, Medical School, Athens, GR, Medicine, Ph.D |
Postgraduate Training
| 2012-2016 | Clinical Fellowship, Hematology/Oncology Fellowship, University of Texas M.D. Anderson Cancer Center, Houston, Texas |
| 2009-2012 | Clinical Residency, Internal Medicine Residency, University of Pennsylvania Health Care System, Philadelphia, Pennsylvania |
| 2008-2009 | Postgraduate Fellow, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2004-2008 | Postgraduate Fellow, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2001-2003 | Postgraduate Fellow, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1998-2002 | Clinical Fellowship, Hematology Fellowship, National and Kapodistrian University of Athens, Athens |
| 1995-1997 | Clinical Residency, Internal Medicine Residency, KAT General Hospital, Athens |
| 1993-1994 | M.D. Social Services, M.D. Social Services, Anthili Fthioditos Health Care Center, Anthili Fthiotidos |
Licenses & Certifications
| 2025 | Oklahoma State Board of Medical Licensure |
| 2024 | Mississippi State Board of Medical Licensure |
| 2024 | Georgia Composite Medical Board |
| 2024 | Arizona Board of Medical Examiners |
| 2024 | Tennessee Board of Medical Examiners |
| 2017 | American Board of Internal Medicine |
| 2014 | American Board of Internal Medicine |
| 2013 | Full Medical License, Texas Medical Board |
| 2007 | E.C.F.M.G / U.S.M.L.E |
| 2003 | Central Board of Health, Greece |
Experience & Service
Faculty Academic Appointments
Assistant Professor of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, Texas, 2021 - 2022
Assistant Professor of Medicine, Internal Medicine, The University of Texas Health Science Center, Houston, TX, 2016 - 2021
Administrative Appointments/Responsibilities
Chair ad-interim, Section of Benign Hematology, Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Rotation Program Director, Section of Benign Hematology, The University of Texas MD Anderson Cancer Center Hematology/Oncology Fellowship Program, Houston, Texas, 2023 - Present
Fellowship Associate Program Director, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center Hematology/Oncology Fellowship Program, Houston, Texas, 2023 - Present
Rotation Program Director, Section of Benign Hematology, The University of Texas MD Anderson Cancer Center Hematology/Oncology Fellowship Program, Houston, Texas, 2023 - Present
Medical Director, Lyndon B. Johnson Hospital, The University of Texas Health Science Center, Houston, Texas, 2020 - 2021
Fellowship Program Site Director, Lyndon B. Johnson Hospital, UTHSC - MD Anderson Cancer Center Hematology/Oncology Fellowship Program, Houston, Texas, 2019 - 2021
Medical Director, Lyndon B. Johnson Hospital, The University of Texas Health Science Center, Houston, Texas, 2019 - 2021
Other Professional Positions
Core Faculty, Hematology/Oncology Fellowship Program, Hematology/Oncology, The University of Texas Health Science Center, Houston, Texas, 2020 - 2021
Core Faculty, Internal Medicine Residency Program, Internal Medicine/Hematology, The University of Texas Health Science Center, Houston, TX, 2018 - 2021
Quality Officer, Hematology, The University of Texas Health Science Center, Houston, TX, 2018 - 2021
Intramural Institutional Committee Activities
Member, Cancer Prevention Chair Search and Election, The University of Texas MD Anderson Cancer Center, 2026 - Present
Extramural Institutional Committee Activities
Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2025 - Present
Associate Program Director, MD Anderson Hematology/Oncology Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Associate Program Director, MD Anderson Hematology/Oncology Fellowship Steering Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Anticoagulation Stewardship Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Blood Transfusion Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Baylor College of Medicine Hematology/Oncology Fellowship Steering Committee, Baylor College of Medicine/Michael E. Debakey VA Medical Center, 2022 - 2022
Member, MD Anderson Hematology/Oncology Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, MD Anderson Hematology/Oncology Fellowship Steering Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Honors & Awards
| 2013 | The Shannon Timmons Fellowship Award on Leukemia Research, The University of Texas MD Anderson Cancer Center |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2023. The Many Faces of Thrombotic Microangiopathy. MD Anderson Internal Medicine Grand Rounds. Houston, TX, US.
- 2021. Clinical Outcomes of Patients with Newly Diagnosed Acute Lymphoblastic Leukemia in Harris County Hospital System. Baylor College of Medicine Hematology/Oncology Grand Rounds. Houston, Texas, US.
- 2020. The Utility of Thrombophilia Testing in Venous and Arterial Thromboembolism. The University of Texas Health Science Center Internal Medicine Grand Rounds. Houston, Texas, US.
- 2018. Thrombocytopenic Emergencies. The University of Texas Health Science Center Community and Family Medicine Grand Rounds. Houston, Texas, US.
- 2018. The Many Faces of Thrombotic Microangiopathies. The University of Texas Health Science Center Internal Medicine Grand Rounds. Houston, Texas, US.
National Presentations
- 2026. Clinical Outcomes of Romiplostm In Chemotherapy-Induced Thrombocytopenia: A single Institution Experience. Poster. European Hematology Association. Stockholm, Stockholm County, SE.
International Presentations
- 2000. Pamidronate Increases Markers of Bone Formation in Patients with Multiple Myeloma in Plateau Phase Under Interferon-Alpha Treatment. Birmingham, GB.
- 2000. Pamidronate Increases Markers of Bone Formation in Patients with Multiple Myeloma in Plateau Phase Under Interferon-Alpha Treatment. Thessaloniki, GR.
- 2000. NTx Concentration is a Specific Marker of the Extent of Bone Involvement in Multiple Myeloma. The Sixth Congress of Internal Medicine. Athens, GR.
- 2000. Phenotype of Paroxysmal Nocturnal Hemoglobinuria in Patients with Acute Leukemias. Thessaloniki, GR.
- 2000. Detection of CD55 and/or CD59 Deficient Red Cell Populations in Patients with Lymphoproliferative Syndromes. Thessaloniki, GR.
- 1999. Variability in Eosinophil Density in Relation to their Concentration in Peripheral Blood. Barcelona, ES.
- 1999. Phenotype of Erythrocytes of NPH Type, in Myeloproliferative Syndromes. Hellenic Medical Congress Proceedings Abstract book:. Athens, GR.
- 1998. A New Short and Intensive Therapeutic Modality for Acute Lymphoblastic Leukemia. Crete/Heraklion, GR.
- 1996. Acute Renal Failure Due to Ciprofloxacin Administration. Hellenic Medical Congress Proceedings. Athens, GR.
- 1996. Therapy of Malaria Caused by Plasmodium Vivax with Quinolones. Hellenic Medical Congress Proceedings. Athens, GR.
- 1996. Postural Psoriatic Arthritis, Imitating Reiter’s Syndrome. Hellenic Medical Congress Proceedings. Athens, GR.
Grant & Contract Support
| Date: | 2025 - Present |
| Title: | STAT-CAT FP00028580 |
| Funding Source: | NIH |
| Role: | Co-PI |
| ID: | FP00028580 |
Selected Publications
Peer-Reviewed Articles
- Apostolidou E, Martinez-Garza MG, Lara-Martinez HR, Oo T, Rojas-Hernandez C. Immune Checkpoint Inhibitor-associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients. J Immunother, 2026. e-Pub 2026. PMID: 42598906.
- Park GS, Atluri H, DiNardo CD, Guillroy B, Horak J, Apostolidou E, Buni M, Bravo GM, Pemmaraju N. Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report. Leuk Res Rep 23:100485, 2025. e-Pub 2025. PMID: 39691506.
- Lu J, Bhakta P, Hwang H, Lachowiez C, Apostolidou E. Clinical Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Treatment in a Safety-Net Hospital System. Clin Lymphoma Myeloma Leuk 25(5):349-356, 2024. e-Pub 2024. PMID: 39799045.
- Goswamy, R, Ajufo, HO, Maiti, A, Brown, RE, Juneja, HS, Apostolidou, E. Refractory Hydroa Vacciniforme-Like Lymphoma. International Journal of Hematology-Oncology and Stem Cell Research 16(3):174-180, 2022. e-Pub 2022. PMID: 36694700.
- Apostolidou, E, Lachowiez, C, Juneja, HS, Qiao, W, Ononogbu, O, Miller-Chism, CN, Udden, MM, Ma, HY, Mims, MP. Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System. Clinical Lymphoma, Myeloma and Leukemia 21(11):e895-e902, 2021. e-Pub 2021. PMID: 34376374.
- Apostolidou E, Kantarjian H, Thomas D, Burger I, Borthakur G, Verstovsek S. Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. Clin Lymphoma Myeloma Leuk 10(4):281-4, 2010. e-Pub 2010. PMID: 20709665.
- Yin CC, Abruzzo LV, Qiu X, Apostolidou E, Cortes JE, Medeiros LJ, Lu G. del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia. Cancer Genet Cytogenet 192(1):18-23, 2009. e-Pub 2009. PMID: 19480932.
- Yee KW, Zeng Z, Konopleva M, Verstovsek S, Ravandi F, Ferrajoli A, Thomas D, Wierda W, Apostolidou E, Albitar M, O'Brien S, Andreeff M, Giles FJ. Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res 12(17):5165-73, 2006. e-Pub 2006. PMID: 16951235.
- Terpos E, Samarkos M, Meletis C, Apostolidou E, Tsironi M, Korovesis K, Mavrogianni D, Viniou N, Meletis J. Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma. Int J Hematol 78(4):344-8, 2003. e-Pub 2003. PMID: 14686493.
- Apostolidou E, Cortes J, Tsimberidou A, Estey E, Kantarjian H, Giles FJ. Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia. Leuk Res 27(10):887-91, 2003. e-Pub 2003. PMID: 12860007.
- Apostolidou E, Estey E, Cortes J, Garcia-Manero G, Faderl S, Thomas D, Tsimberidou A, Kantarjian H, Giles FJ. Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia. Leuk Res 27(4):301-4, 2003. e-Pub 2003. PMID: 12531220.
- Alvarado Y, Kantarjian HM, Cortes JE, Apostolidou E, Bivins C, Giles FJ. Troxacitabine activity in extramedullary myeloid leukemia. Hematology 7(3):179-85, 2002. e-Pub 2002. PMID: 12243982.
- Meletis J, Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Anargyrou K, Korovesis K, Mavrogianni D, Variami E, Viniou N, Konstantopoulos K. Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia. Hematology 7(2):69-74, 2002. e-Pub 2002. PMID: 12186694.
- Viniou N, Terpos E, Galanopoulos A, Kritikou-Griva E, Akel S, Michalis E, Apostolidou E, Georgiadou D, Kouraklis A, Parharidou A, Kokkini G, Symeonidis A, Anagnostopoulos NI, Christakis JI, Tasiopoulou A, Loukopoulos D, Yataganas X. Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response. Ann Hematol 81(4):182-6, 2002. e-Pub 2002. PMID: 11976818.
- Meletis J, Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Korovesis K, Anargyrou K, Benopoulou O, Mavrogianni D, Variami E, Viniou N, Konstantopoulos K. Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias. Int J Hematol 75(1):40-4, 2002. e-Pub 2002. PMID: 11843289.
- Korkolopoulou P, Apostolidou E, Pavlopoulos PM, Kavantzas N, Vyniou N, Thymara I, Terpos E, Patsouris E, Yataganas X, Davaris P. Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia 15(9):1369-76, 2001. e-Pub 2001. PMID: 11516097.
- Meletis J, Dalekou M, Samarkos M, Paravasiliou E, Meletis C, Konstantopoulos K, Apostolidou E, Komninaka V, Terpos E, Benopoulou O, Korovesis K, Variami E, Loukopoulos D. Fetal Erythropoiesis after Allogeneic Bone Marrow Transplantation Estimated by the Peripheral Blood Erythrocytes Containing Hemoglobin F (F-cells). Hematology 5(6):447-53, 2001. e-Pub 2001. PMID: 27419348.
- Meletis J, Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Korovesis K, Mavrogianni D, Boutsis D, Variami E, Viniou N, Konstantopoulos K, Loukopoulos D. Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes. Hematol J 2(1):33-7, 2001. e-Pub 2001. PMID: 11920231.
- Meletis J, Terpos E, Samarkos M, Meletis C, Konstantopoulos K, Komninaka V, Apostolidou E, Benopoulou O, Korovesis K, Mavrogianni D, Variami E, Yataganas X, Loukopoulos D. Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders. Haematologia (Budap) 31(1):7-16, 2001. e-Pub 2001. PMID: 11345408.
Review Articles
- Apostolidou E, Kantarjian HM, Verstovsek S. JAK2 inhibitors: A reality? A hope?. Clin Lymphoma Myeloma 9 Suppl 3:S340-5, 2009. e-Pub 2009. PMID: 19778862.
- Alvarado Y, Apostolidou E, Swords R, Giles FJ. Emerging therapeutic options for Philadelphia-positive acute lymphocytic leukemia. Expert Opin Emerg Drugs 12(1):165-79, 2007. e-Pub 2007. PMID: 17355221.
- Apostolidou E, Swords R, Alvarado Y, Giles FJ. Treatment of acute lymphoblastic leukaemia : a new era. Drugs 67(15):2153-71, 2007. e-Pub 2007. PMID: 17927282.
- Swords R, Apostolidou E, Giles F. Troxacitabine in leukemia. Hematology 11(5):321-9, 2006. e-Pub 2006. PMID: 17607581.
- Meletis J, Terpos E, Mavrogianni D, Lilakos K, Apostolidou E, Tsironi M, Korovessis K, Komninaka V, Sarantopoulos A, Samarkos M, Konstantopoulos K. Aplastic anemia with large ‘PNH – like’ red cell population. Haema 6(1):103-106, 2003. e-Pub 2003.
- Meletis J, Terpos E, Tsironi M, Komninaka V, Apostolidou E, Samarkos M. Flashes in clinical haematology – case 22: Type II mixed cryoglobulinemia, HCV-associated peripheral neuropathy. Haema 6(2):256-57, 2003. e-Pub 2003.
- Meletis J, Terpos E, Tsironi M, Komninaka V, Apostolidou E, Samarkos M. Flashes in clinical haematology- case 21 :Type –I Gaucher’s disease with monoclonal gammopathy of unknown significance. Haema 6(1):107-108, 2003. e-Pub 2003.
- Meletis J, Terpos E, Tsironi M, Komninaka V, Apostolidou E, Samarkos M, Vaiopoulos G. Flashes in clinical haematology – case 23: Cutaneous T-cell lymphoma; Sezary syndrome. Haema 6(3):409-10, 2003. e-Pub 2003.
- Meletis J, Terpos E, Komninaka V, Tsironi M, Apostolidou E, Samarkos M, Vaiopoulos G. Flashes in clinical haematology – case 25: Chronic lymphocytic leukemia, autoimmune haemolytic anaemia, Kaposi’s sarcoma. Haema 6(4):544-45, 2003. e-Pub 2003.
- Meletis J, Terpos E, Apostolidou E, Tsironi M, Samarkos M. Acute monoblastic leukemia – leukemia cutis after progression of refractory anemia with ringed side oblasts and multilineage dysplasia. Archives of Hellenic Medicine 19(6):710-12, 2002. e-Pub 2002.
- Meletis J, Terpos E, Apostolidou E, Samarkos M. Flashes in clinical haematology- case 18: Inherited orotic aciduria type I. Haema 5(2):136-37, 2002. e-Pub 2002.
- Meletis J, Anargyrou K, Terpos E, Apostolidou E, Tsironi M, Samarkos M. Flashes in clinical haematology-case 20: Secondary acute non-lymphoblastic leukemia. Haema 5(4):347, 2002. e-Pub 2002.
- Meletis J, Terpos E, Apostolidou E, Anargyrou K, Samarkos M. Flashes in clinical hematology- case 19 : Plasmacytic leukemia, pseudomonas aeruginosa sepsis. Haema 5(3):249-50, 2002. e-Pub 2002.
- Terpos E, Pamphilis C, Tsironi M, Apostolidou E, Komninaka V, Samarkos M, Chatzinikolaou P, Korovesis K, Kostantopoulos K, Yataganas X, Meletis J. Hemophagocytic syndrome associated with adrenocortical carcinoma: a case report and review of the literature. Haema 5(2):136-37, 2002. e-Pub 2002.
- Meletis J, Apostolidou E, Terpos E, Samarkos M. Flashes in clinical hematology- case 13: Anaplastic myeloma. Haema 4(1):52-53, 2001. e-Pub 2001.
- Apostolidou E. Hereditary stomatocytosis with megaloblastic anemia 18(4):416, 2001. e-Pub 2001.
- Meletis J, Terpos E, Apostolidou E, Samarkos M. Lead poisoning. Archives of Hellenic Medicine 18(5):538, 2001. e-Pub 2001.
- Meletis J, Apostolidou E, Komninaka V, Samarkos M. Anaplastic Myeloma. Archives of Hellenic Medicine 17(1):109-12, 2000. e-Pub 2000.
- Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Meletis JC. Detection of CD55 and /or CD59 deficient red cell populations in patients with myeloproliferative syndromes. Iatriki 77(5):471-75, 2000. e-Pub 2000.
- Meletis J, Terpos E, Komninaka V, Apostolidou E. Essential mixed cryoglobulinemia (type II: with monoclonal and polyclonal component). Archives of Hellenic Medicine 17(6):641, 2000. e-Pub 2000.
- Meletis J, Apostolidou E, Komninaka V, Samarkos M. Flashes in clinical haematology - case 10: CLL-prolymphocytic leukemia - VZV infection. Haema 3(2):119-20, 2000. e-Pub 2000.
- Meletis J, Apostolidou E, Komninaka V, Samarkos M. Flashes in clinical haematology - case 11: Malaria. Megaloblastic anemia (folic acid deficiency). Haema 3(2):193-94, 2000. e-Pub 2000.
- Meletis J, Terpos E, Apostolidou E, Samarkos M. Flashes in clinical haematology - case 12: Haemoglobin E disease with erythroblastopenia. Haema 3(4):242-43, 2000. e-Pub 2000.
- Meletis J, Apostolidou E, Komninaka V, Samarkos M. Flashes in clinical haematology - case 9: AML type M3 variant, mild disseminated intravascular coagulation. Haema 3(1):60-61, 2000. e-Pub 2000.
- Meletis J, Terpos E, Apostolidou E, Samarkos M. Cutaneous T-cell lymphoma; Sezary syndrome. Archives of Hellenic Medicine 17(4):418-421, 2000. e-Pub 2000.
- Meletis J, Apostolidou E, Konstantopoulos K. Flashes in clinical haematology - case 6: SLE- vasculitis-cold hemagglutinin disease (CHAD). Haema 2(2):109, 1999. e-Pub 1999.
Other Articles
- Meletis J, Terpos E, Apostolidou E, Samarkos M Hereditary stomatocytosis with megaloblastic anemia. Archives of Hellenic Medicine 18(4):416, 2001.
- Terpos E, Samarkos M, Meletis C, Komninaka V, Apostolidou E, Benopoulou O, Korovesis K, Mavrogianni D, Anargyrou K, Viniou N, Variami E, Konstantopoulos K, Meletis J Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anemia and myelodysplastic syndromes. Archives of Hellenic Medicine, 2000.
- Meletis J, Terpos E, Apostolidou E, Komninaka V Haemolytic anaemia, Leishmania Donovani infection, bone marrow plasmacytosis. Archives of Hellenic Medicine 17(5):532, 2000.
Abstracts
- Lu J, Bhakta P, Lachowiez C, Apostolidou E. Clinical Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia Receiving Treatment in a Safety-Net Hospital System. American Society of Clinical Oncology (ASCO) 2023 41(16):7035, 2023. e-Pub 2023.
- Apostolidou E, Lachowiez C, Qiao W, Lee S, Ma H, Short N, Idowu M, Mims M, Juneja H. Clinical Outcomes of Patients with Acute Lymphoblastic Leukemia in a County Hospital System - Society of Hematologic Oncology Annual Meeting, Clinical Lymphoma, Myeloma and Leukemia. Society of Hematologic Oncology (SOHO) Annual Meeting 2020 20(Suppl_1):108-109, 2020. e-Pub 2020.
- Apostolidou E, Khatri P, Thomas E, Savitz SI, Zha A. Utility and Costs of Inpatient Thrombophilia Testing in Ischemic Stroke Patients Aged 18-60. International Stroke Conference 2020 51(Issue Suppl_1), 2020. e-Pub 2020.
- Apostolidou E, Hatami M, Savitz SI, Thomas E, Khatri P, Zha A. Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke. The 61st Annual Meeting of the American Society of Hematology (ASH) 134(Suppl.1):3397, 2019. e-Pub 2019.
- Roboz GJ, Giles FJ, List AF, Apostolidou E Rae PE, Dugan M, Oasman SJ, Schuster MW, Laurent D, Feldman EJ. Phase I trial of PTK787/ZK 222584 (PTK/ZK), an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The Thirty-ninth Annual Meeting of the American Society of Clinical Oncology (ASCO)(22):568, 2003. e-Pub 2003.
- Apostolidou E, List A, Roboz G, Feldman E, Rae P, Dugan M, Reitsma D, Laurent D, Kantarjian H, Giles F. Phase I/II study of PTK787/ZK 222584 in patients with myelofibrosis. The Ninety- fourth Annual Meeting of the American Association for Cancer Research (AACR)(44):1226, 2003. e-Pub 2003.
- Apostolidou E, Cortes J, Tsimberidou A, Estey E, Kantarjian H, Giles F. Mylotarg, Liposomal Daunorubicin, Ara-C and Cyclosporine (MDAC) regimen in patients with relapsed /refractory acute myelogenous leukemia (AML). The Forty-fourth Annual Meeting of the American Society of Hematology (ASH) 100(11):268b, 2002. e-Pub 2002.
- Apostolidou E, Garcia-Manero G, Cortes J, Thomas D, Andreef M, Keating M, Kantarjian H, Giles F. Phase I study of OSI-211, a novel Topo I inhibitor in myeloid leukemias. The Forty-fourth Annual Meeting of the American Society of Hematology (ASH) 100(11):262b, 2002. e-Pub 2002.
- Apostolidou E, Garcia-Manero G, Cortes J, Thomas D, Andreef M, Keating M, Kantarjian H, Giles F. Phase I study of OSI-211, a novel Topo I inhibitor in myeloid leukemias. The Forty-fourth Annual Meeting of the American Society of Hematology (ASH) 100(11):262b, 2002. e-Pub 2002.
- Anagnostopoulos N, Viniou N, Galanopoulos A, Terpos E, Griva E, Salem A, Michalis E, Apostolidou E, Kouraklis A, Kokkini G, Parharidou A, Christakis J, Pangalis G, Tassiopoulou A, Loukopoulos D, Yataganas X. Treatment of anemia in myelodysplastic syndromes with amifostine. In vitro testing of response. The Forty-second Annual Meeting of the American Society of Hematology (ASH) 96(11):259b, 2000. e-Pub 2000.
- Apostolidou E, Korkolopoulou P, Viniou N, Kavantzas N, Patsouris E, Yataganas X, Davaris P. A morphometric study of neovascularization in myelodysplastic syndromes (MDS). The Forty-second Annual Meeting of the American Society of Hematology (ASH) 96(11):355a, 2000. e-Pub 2000.
- Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Boutsis D, Mavrogianni D, Viniou N, Meletis J. Phenotype of Paroxysmal Nocturnal Haemoglobinuria in patients with acute leukemias. The Eleventh Congress of the Hellenic Society of Hematology 3(Suppl 1):271, 2000. e-Pub 2000.
- Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Anargyrou K, Mavrogianni D, Variami E, Meletis J. Detection of CD55 and/or CD59 deficient red cell populations in patients with lymphoproliferative syndromes. The Eleventh Congress of the Hellenic Society of Hematology 3(1):232-233, 2000. e-Pub 2000.
- Terpos E, Anargyrou K, Apostolidou E, Viniou N, Meletis J, Loukopoulos D, Yataganas X. Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment. The Eleventh Congress of the Hellenic Society of Hematology 3(Suppl. 1):129, 2000. e-Pub 2000.
- Anagnostopoulos N, Viniou N, Galanopoulos A, Terpos E, Griva E, Salem A, Michalis E, Apostolidou E, Kouraklis A, Kokkini G, Parharidou A, Christakis J, Pangalis G, Tassiopoulou A, Loukopoulos D, Yataganas X. Treatment of anemia in myelodysplastic syndromes with amifostine. In vitro testing of response - Greek MDS Study Group. The Eleventh Congress of the Hellenic Society of Hematology 3(1):122-123, 2000. e-Pub 2000.
- Apostolidou E, Korkolopoulou P, Viniou N, Kavantzas N, Patsouris E, Akel S, Terpos E, Anargyrou K, Stamatopoulos K, Davaris P, Yataganas X. Morphometric analysis of angiogenesis in patients with myelodysplastic syndromes. The Eleventh Congress of the Hellenic Society of Hematology 3(1):289, 2000. e-Pub 2000.
- Terpos E, Mitsouli C, Tsionos C, Anargyrou K, Apostolidou E, Papanikolaou G, Vasilaki M, Charchalakis N, Meletis J. NTx concentration is a specific marker of the extent of bone involvement in multiple myeloma. The Sixth Congress of Internal Medicine(62):113, 2000. e-Pub 2000.
- Terpos E, Palermos J, Anargyrou K, Apostolidou E, Meletis J, Yataganas X. Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment. The Fifth Annual Meeting of the European Hematology Association (EHA) 1(Suppl. 1):168, 2000. e-Pub 2000.
Book Chapters
- Apostolidou E. Cancer Associated Thrombosis. In: The MD Anderson Manual of Medical Oncology. Fifth Edition. McGraw Hill Publishing, 2025.
- Apostolidou E. Hematology and Oncology. In: Mc Graw Hill's Critical Care Examination and Board Review 2e. McGraw Hill Publishing.
Letters to the Editor
- Khan, S, Alam, ST, Ramos, RT, Mbue, JE, Apostolidou, E, Rivero, GA, Yellapragada, S. Luspatercept in Low-Risk Myelodysplastic Syndrome. Clinical Hematology International 4: 148-151, 2022.
- Hu, Z, Singhi, EK, Apostolidou, E, Mai, B, Juneja, HS, Hu, S. Mass-forming neoplastic extramedullary hematopoiesis mimics myeloid sarcoma in a patient with chronic phase chronic myeloid leukemia. International Journal of Laboratory Hematology 43: e135-e137, 2021.
Web Publications
- Apostolidou E. Associations of clonal haematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke - A commentary.
- Apostolidou E. Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents - A commentary.
- Apostolidou E. Venous and arterial thrombosis associated with Abemaciclib therapy for metastatic breast cancer - A commentary.
Patient Reviews
CV information above last modified August 29, 2026